The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.

Yildiz, RamazanBuyukberber, SuleymanKoca, DoganKorai, LokmanCiltas, AydinUnal, Olcun UmitGumus, Mahmut2024-04-242024-04-2420130732-183X1527-7755https://hdl.handle.net/11468/2312649th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 31-JUN 04, 2013 -- Chicago, IL[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.Conference Object3115WOS:000335419603655Q1